16.12.2019 Views

Waikato Business News RECAP 2019

A wrap up of the year’s success, innovation and growth stories in the Waikato business community

A wrap up of the year’s success, innovation and growth stories in the Waikato business community

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

WAIKATO FIRM POISED<br />

FOR MEDICINAL CANNABIS WAVE<br />

<strong>Waikato</strong> Innovation Park-based medicinal cannabis firm<br />

Cannasouth made headlines when it listed on the New<br />

Zealand Stock Exchange in June.<br />

THE STORY THEN:<br />

Aug 1 - <strong>Waikato</strong> firm Cannasouth has been<br />

building a big surfboard. That’s because it’s got<br />

a big wave to catch.<br />

The wave is medicinal cannabis and the analogy<br />

comes from the company’s chief executive,<br />

Mark Lucas.<br />

Cannasouth recently listed on the NZX, the first<br />

company to do so in two years, and the first<br />

medicinal cannabis company to take the step.<br />

It recently appointed a new product development<br />

manager, scientist David Gill, and is<br />

well underway with developing cannabinoid<br />

products using its labs at Innovation Park and<br />

Hamilton East’s secure growing facility.<br />

Timing is everything, and the introduction of the<br />

Misuse of Drugs (Medicinal Cannabis) Amendment<br />

Act last year has been followed by the<br />

release for feedback in July of a discussion document<br />

aimed at setting up a regulatory scheme,<br />

with Cannasouth set to be among those submitting<br />

before the August 7 cutoff.<br />

“It’s like surfing,” Lucas says. “The big wave<br />

surfers get on the weather maps and they know<br />

when there’s a storm out there. It might be a<br />

week before the waves arrive. They fly to to get<br />

those waves. But to surf big waves you need a<br />

big board.<br />

“We were out there and we realised, well this<br />

wave’s pretty big; to compete, or to get on the<br />

wave, we need to build a big board and that’s<br />

raising capital.”<br />

The listing in June at 50c a share was oversubscribed<br />

and saw the company raise $10 million.<br />

Lucas is at pains to stress they are in for the long<br />

haul, after being frustrated by some negative<br />

media commentary around the listing, which he<br />

says implied the cofounders and early investors<br />

would look to quickly sell their shares.<br />

The price has since steadied around 37c at time<br />

of writing, and Lucas says the share price may<br />

have been affected by the commentary, as well<br />

as potential confusion around the medicinal cannabis<br />

scheme and the adult recreational debate.<br />

Cannasouth has been heavily involved in<br />

research, developing its own IP, but Lucas and<br />

chief operating officer Nic Foreman recognise<br />

the commercial realities as well.<br />

“There’s going to be a lot of competition but the<br />

space itself is also looking like it’s going to be<br />

rather large.”<br />

The medicinal potential of cannabinoids has<br />

been touted as potentially helping with a range<br />

of conditions from anxiety, through inflammation<br />

to epilepsy and Crohn’s Disease among others.<br />

RESEARCH HAS BEEN A FOCUS FOR CHIEF EXECUTIVE<br />

MARK LUCAS AND THE CANNASOUTH TEAM.<br />

Exporting is part of Cannasouth’s plan and it<br />

intends to take a broad approach in the market;<br />

while its focus has been on developing medicines,<br />

there is also potential in neutraceuticals<br />

potentially including fortified waters and sports<br />

recovery drinks.<br />

The “holy grail” would be to come up with<br />

their own medicine that can treat a specific<br />

condition and be “novel and unique”.<br />

THE STORY SINCE:<br />

In August, Cannasouth announced a longterm<br />

strategic joint venture (JV) with Aaron<br />

Craig and his family (Craig Family Interests) to<br />

construct and develop a world-class cannabis<br />

cultivation facility in <strong>Waikato</strong>.<br />

The JV will construct and operate a medicinal<br />

cannabis and hemp cultivation and production<br />

facility, which will service and supply Cannasouth’s<br />

production requirements. It is expected<br />

to be fully operational by mid-2020.<br />

Also in August, Cannasouth harvested its first<br />

crop of medicinal research cannabis from its<br />

purpose-built growing facility in Hamilton.<br />

By September, the total number of individual<br />

registered investors in Cannasouth passed<br />

2000, up from the approximately 1450 following<br />

its listing in June. At the start of October,<br />

Cannasouth entered into an agreement to<br />

acquire a 60 percent shareholding in Hawke’s<br />

Bay-based Midwest Pharmaceutics NZ Limited<br />

for a purchase price of $1.32 million. The<br />

acquisition will add significantly to the suite of<br />

licences that can be utilised by the Cannasouth<br />

group.<br />

In early December, Cannasouth shares were<br />

trading around 63c.<br />

GET THE WAIKATO’S AWARD WINNING ELECTRICAL EXPERTS ON THE JOB TODAY<br />

MASTER ELECTRICIANS<br />

EXCELLENCE AWARDS<br />

<strong>2019</strong><br />

SILVER FOR PROJECT<br />

“HILTON” $1-5 MILLION<br />

RAISING THE BARR IN ELECTRICAL SERVICE<br />

WHERE QUALITY & SERVICE COUNT<br />

For your next Electrical Project talk to the award<br />

winning team at RichmondBarr Electrical<br />

Commercial Electric Projects<br />

Electrical Service<br />

Heavy Industrial<br />

Communication & Automation<br />

Design & Bulk Projects<br />

Commercial Kitchens<br />

MORE THAN JUST ELECTRICIANS<br />

Call us 24 hours 07 847 9845<br />

service@richmondbarr.co.nz<br />

www.richmondbarr.co.nz<br />

203710AA<br />

8 WAIKATO BUSINESS NEWS - <strong>RECAP</strong> December <strong>2019</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!